Revvity | PKI - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Agilent USD 29M 4M 2026-06
Align Technology USD 6.93M 9.11M 2026-03
Bio Techne USD 3.6M 1.19M 2026-06
Bio-Rad Laboratories USD 12.1M 200K 2026-06
Bruker USD 17.8M 9.7M 2026-06
Celltrion KRW 19B 1.96B 2025-06
Charles River Laboratories USD 30.34M 3.6M 2026-06
Cspc Pharmaceutical CNY 6.76M 3.43M 2025-12
Danaher USD 107M 44M 2026-06
Dentsply International USD 22M 2M 2026-06
Deva Holding AS TRY 272.53M 69.04M 2023-09
Dianthus Therapeutics USD 4.44M 263K 2024-09
Divis Laboratories Ltd INR 60M 0 2026-06
Edwards Lifesciences USD 30M 5.9M 2026-06
Illumina USD 24M 2M 2026-03
Intuitive Surgical USD 20.88B 765.6M 2026-06
IQVIA Holdings USD 197M 5M 2026-06
Kangmei Pharma CNY 1.82M 150K 2025-09
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Laboratorios Farma EUR 699K 666.2K 2025-06
Laboratory Of America USD 61.1M 6M 2026-06
Medical Developments International AUD 18K 3K 2025-06
Mesa Laboratories USD 3.02M 180K 2024-09
Mettler Toledo International USD 17.25M 239K 2026-06
Myriad Genetics USD 4.4M 600K 2025-12
Neuren Pharmaceuticals AUD 0 0 2024-06
OraSure Technologies 1.67M 1.13M 2025-12
Organigram Holdings CAD 179K 127K 2025-03
Ovoca Bio EUR 7K 6K 2022-06
Pacific Biosciences Of California USD 1.74M 1000 2025-12
Pharma Mar EUR 117K 1.24M 2025-09
Qiagen NV USD 10.02M 1.03M 2026-06
Quest Diagnostics USD 69M 2M 2025-09
Quidel USD 5.63B 5.58B 2026-03
Repligen USD 5.66M 85K 2026-06
Revvity USD 22.99M 1.73M 2026-06
Sartorius EUR 49.5M 8.1M 2025-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Thermo Fisher Scientific USD 354M 11M 2026-03
Tilray USD 6.7M 2.73M 2025-06
Waters USD 55M 13M 2026-06
Zealand Pharma A/S 7.07M 74K 2025-12
Zz Pientze Pharmaceu CNY 46.05M 36.5M 2025-06